Clinically, insulin metabolism and HOMA-IR (Insulin resistance index) were significantly higher in patients with DM1 than control group [27,28,55,56,57,58,59,60,61,62] as demonstrated in Table 2. The gene discussed is INS; the disease is myotonic dystrophy type 1.